Alzheimer’s

Alzheimer's disease is more common in older adults with dementia.

Drug development possibilities for brain diseases linked to tau protein.

Model tested on tens of thousands of routine brain scans spotted disease risk with 90% accuracy.

It highlights the knowledge gap needed to reduce cognitive decline.

Obesity-related neurodegeneration mimics Alzheimer’s disease.

The study supports the idea that components in the human blood can modulate the formation of new brain cells.

Blood-based markers may reveal Alzheimer's disease ten years before symptoms show.

This treatment option is the latest therapy to target.

A clue to the molecular cause of Alzheimer’s.

A modified immune protein harming brain connections is much more common in the brains of women with Alzheimer’s.

If we can find these individuals early enough, we’ll have a better chance of seeing if the drugs are effective.

The discovery provides a new therapeutic target to prevent the onset of neurodegenerative diseases.